The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

California could see an early and especially sharp start to the annual flu season, as a combination of low vaccination rates ...

The agency also approved epcoritamab (Epkinly) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma ...

While flu levels are still low, a strain that's wreaked havoc in the U.K. and Canada is behind most cases so far in the U.S., ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Heading into the holidays, Maryland is seeing low levels of flu, COVID and RSV. Doctors said it's important to get your ...

Most flu deaths occur in people 65 and older, but the right vaccine can help. Health experts recommend three specific flu ...

The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K ...

The U.S. flu season is starting slowly, and it’s not clear if it will be as bad as last winter’s. But some health experts are ...